Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.22)
# 2,749
Out of 4,915 analysts
343
Total ratings
43.13%
Success rate
-4.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMS Alumis | Reiterates: Buy | $14 | $4.10 | +241.46% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $16.26 | +515.01% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $13.71 | +228.23% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $40.41 | +85.60% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $11.15 | +169.06% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $26.66 | +65.04% | 14 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $65 | $57.68 | +12.69% | 4 | Jun 27, 2025 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $50 | $43.37 | +15.29% | 4 | Jun 26, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $16.75 | -40.30% | 14 | Jun 25, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $1 → $10 | $12.44 | -19.61% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $12.33 | +143.31% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $27.01 | +362.79% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $6.65 | +125.56% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.17 | +327.35% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $60.08 | +19.84% | 36 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $3.74 | +33.69% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.32 | +115.52% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $4.65 | +222.58% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $21.87 | +105.76% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.52 | +19.05% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.80 | +212.50% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.48 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $2.27 | +208.37% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.44 | +108.33% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.57 | +251.25% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.55 | +1,545.04% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.80 | +120.59% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.10 | +55,454,445.45% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.90 | - | 4 | Jun 2, 2023 |
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.10
Upside: +241.46%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $16.26
Upside: +515.01%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $13.71
Upside: +228.23%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $40.41
Upside: +85.60%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $11.15
Upside: +169.06%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $26.66
Upside: +65.04%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Buy
Price Target: $65
Current: $57.68
Upside: +12.69%
Ionis Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $50
Current: $43.37
Upside: +15.29%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $16.75
Upside: -40.30%
Lyell Immunopharma
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $12.44
Upside: -19.61%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $12.33
Upside: +143.31%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $27.01
Upside: +362.79%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $6.65
Upside: +125.56%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.17
Upside: +327.35%
May 29, 2025
Reiterates: Buy
Price Target: $72
Current: $60.08
Upside: +19.84%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $3.74
Upside: +33.69%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.32
Upside: +115.52%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $4.65
Upside: +222.58%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.87
Upside: +105.76%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.52
Upside: +19.05%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.80
Upside: +212.50%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.48
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $2.27
Upside: +208.37%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.44
Upside: +108.33%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.57
Upside: +251.25%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.55
Upside: +1,545.04%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $6.80
Upside: +120.59%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.10
Upside: +55,454,445.45%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.90
Upside: -